BIOCON LTD.

NSE : BIOCONBSE : 532523ISIN CODE : INE376G01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE307.0016.25 (+5.59 %)
PREV CLOSE ( ) 290.75
OPEN PRICE ( ) 292.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2175825
TODAY'S LOW / HIGH ( )292.00 313.35
52 WK LOW / HIGH ( )217.5 313.35
NSE306.4014.75 (+5.06 %)
PREV CLOSE( ) 291.65
OPEN PRICE ( ) 292.00
BID PRICE (QTY) 306.40 (44807)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 45364974
TODAY'S LOW / HIGH( ) 292.00 313.40
52 WK LOW / HIGH ( )217.5 313.4
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax8971.009831.0010677.0011860.0012149.00
Adjustment16850.0012450.007096.006063.002603.00
Changes In working Capital-5010.00-7895.00-4238.00-1651.00-291.00
Cash Flow after changes in Working Capital20811.0014386.0013535.0016272.0014461.00
Cash Flow from Operating Activities18525.0011766.0011597.0012831.0011546.00
Cash Flow from Investing Activities-142818.00-16991.00-36247.00-15589.00-7138.00
Cash Flow from Financing Activities130487.002421.0025640.003876.00-2417.00
Net Cash Inflow / Outflow6194.00-2804.00990.001118.001991.00
Opening Cash & Cash Equivalents6537.008970.008247.006593.004490.00
Cash & Cash Equivalent on Amalgamation / Take over / MergerNA338.00-338.00NANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange Fluctuations217.0033.0071.00536.00112.00
Closing Cash & Cash Equivalent12948.006537.008970.008247.006593.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.